Protective genes in the vessel wall: Modulators of graft survival and function

Transplantation

Volumn 82, Issue SUPPL. 1, 2006, Pages

  Ferran, Christiane ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

A20; Apoptosis; Bcl xL; HO 1; Inflammation; Transplant arteriosclerosis

Indexed keywords

HEAT SHOCK PROTEIN; HEME OXYGENASE; INDUCIBLE NITRIC OXIDE SYNTHASE; PROTEIN BCL 2; PROTEIN BCL XL; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; ZINC FINGER PROTEIN A20;

ALLOIMMUNITY; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTERIOSCLEROSIS; BLOOD VESSEL WALL; CELL GROWTH; CELL INTERACTION; CONFERENCE PAPER; DELAYED HYPERSENSITIVITY; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE FUNCTION; GRAFT SURVIVAL; HEALING; HUMAN; INFLAMMATION; PHENOTYPE; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; STEM CELL;

ANIMALS; APOPTOSIS; ARTERIOSCLEROSIS; BLOOD VESSELS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; GRAFT SURVIVAL; INFLAMMATION;

EID: 33745845199     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000231445.62162.d5     Document Type: Conference Paper

References (29)

1. Cecka JM. The UNOS scientific renal transplant registry. Clin Transpl 1999; 13: 1.
2. Behrendt D, Ganz P, Fang JC. Cardiac allograft vasculopathy. Curr Opin Cardiol 2000; 15: 422.
3. Tullius SG, Tilney NL. Both alloantigen-dependent and -independent factors influence chronic allograft rejection. Transplantation 1995; 59: 2126.
4. Shi C, Lee W-S, He Q, et al. Immunologic basis of transplant-associated arteriosclerosis. Proc Natl Acad Sci U S A 1996; 93: 4051.
5. Suzuki JI, Isobe M, Morishita R, et al. Antisense Bcl-x oligonucleotide induces apoptosis and prevents arterial neointimal formation in murine cardiac allogratts. Cardiovasc Res 2000; 45: 783.
6. Koyama H, Raines EW, Borfeldt KE, et al. Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors. Cell 1996; 87: 1069.
7. Hancock WW, Buelow R, Sayegh MH, Turka LA. Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes. Nature Med 1998; 4: 1392.
8. Libby P, Pober JS. Chronic rejection. Immunity 2001; 14: 387.
9. Bach FH, Hancock WW, Ferran C. Protective genes expressed in endothelial cells: a regulatory response to injury. Immunol Today 1997; 18: 483.
10. Bach FH, Ferran C, Hechenleitner P, et al. Accommodation of vascularized xenografts: expression of "protective genes" by donor endothelial cells in a host Th2 cytokine environment. Nature Med 1997; 3: 196.
11. Kunter U, Floege J, von Jurgensonn AS, et al. Expression of A20 in the vessel wall of rat-kidney allografts correlates with protection from transplant arteriosclerosis. Transplantation 2003; 75: 3.
12. Simper D, Wang S, Deb A, et al. Endothelial progenitor cells are decreased in blood of cardiac allograft patients with vasculopathy and endothelial cells of noncardiac origin are enriched in transplant atherosclerosis. Circulation 2003; 108: 143.
13. Opipari AJ, Boguski MS, Dixit VM. The A20 cDNA induced by tumor necrosis factor alpha encodes a novel type of zinc finger protein. J Biol Chem 1990; 265: 14705.
14. Daniel S, Arvelo MB, Patel VI, et al. A20 protects endothelial cells from TNF-, Fas-, and NK-mediated cell death by inhibiting caspase 8 activation. Blood 2004; 104: 2376.
15. Cooper JT, Stroka DM, Brostjan C, et al. A20 blocks endothelial cell activation through a NF-κB-dependent mechanism. J Biol Chem 1996; 271: 18068.
16. Ferran C, Stroka DM, Badrichani AZ, et al. A20 inhibits NF-κB activation in endothelial cells without sensitizing to TNF-mediated apoptosis. Blood 1998; 91: 2249.
17. Longo CR, Arvelo MB, Patel VI, et al. A20 protects from CD40-CD40 ligand-mediated endothelial cell activation and apoptosis. Circulation 2003; 108: 1113.
18. Wang CY, Mazer SP, Minamoto K, et al. Suppression of murine cardiac allograft arteriopathy by long-term blockade of CD40-CD154 interactions. Circulation 2002; 105: 1609.
19. Lee EG, Boone DL, Chai S, et al. Failure to regulate TNF-induced NF-κB and cell death responses in A20-deficient mice. Science 2000; 289: 2350.
20. Randolph GJ, Beaulieu S, Lebecque S, et al. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science 1998; 282: 480.
21. Phipps RP. Atherosclerosis: The emerging role of inflammation and the CD40-CD40 ligand system. Proc Natl Acad Sci U S A 2000; 97: 6930.
22. Arvelo MB, Badrichani AZ, Stroka DM, et al. A Novel Function For A20 In Smooth Muscle Cells: Inhibition of Proliferation and Activation. Transplant Proc 1999; 31: 858.
23. Badrichani AZ, Stroka DM, Bilbao G, et al. Bcl-2 and Bcl-xL serve an anti-inflammatory function in endothelial cells through inhibition of NF-κB. J Clin Invest 1999; 103: 543.
24. Stroka DM, Badrichani AZ, Bach FH, Ferran C. Overexpression of A1, an NF-κB-inducible, anti-apoptotic Bcl gene inhibits endothelial cell activation. Blood 1999; 93: 3803.
25. Blanc-Brude OP, Yu J, Simosa H, et al. Inhibitor of apoptosis protein survivin regulates vascular injury. Nature Med 2002; 9: 987.
26. Brouard S, Otterbein LE, Anrather J, et al. Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J Exp Med 2000; 192: 1015.
27. Otterbein LE, Zuckerbraun BS, Haga M, et al. Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury. Nature Med 2003; 9: 183.
28. Akamatsu Y, Haga M, Tyagi S, et al. Heme oxygenase-1-derived carbon monoxide protects hearts from transplant associated ischemia reperfusion injury. FASEB J 2004; 18: 771.
29. Shears LLI, Kawaharada N, Tzeng E, et al. Inducible nitric oxide synthase suppresses the development of allograft arteriosclerosis. J Clin Invest 1997; 100: 2035.